Kimon Argyropoulos earned his MD from the National and Kapodistrian University of Athens, Greece, in 2011. His research focuses on the immunobiology of indolent lymphoid neoplasms, with an emphasis on aberrant lymphocyte signaling as a potent driver of human lymphomagenesis. He is a recipient of the SASS Foundation post-doctoral fellowship award for his studies on BCR signaling in Waldesntröm’s Macroglobulinemia.